Cargando…
Novel targeted drugs for follicular and marginal zone lymphoma: a comprehensive review
Although mostly incurable, indolent non-Hodgkin lymphomas (iNHL) are chronic diseases with a median overall survival approaching 20 years. In recent years, important advances in the knowledge of the biology of these lymphomas have led to the development of new drugs, mostly chemotherapy-free, with p...
Autores principales: | Rivero, Andrea, Mozas, Pablo, Magnano, Laura, López-Guillermo, Armando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189145/ https://www.ncbi.nlm.nih.gov/pubmed/37207160 http://dx.doi.org/10.3389/fonc.2023.1170394 |
Ejemplares similares
-
Follicular lymphoma and marginal zone lymphoma: how many diseases?
por: Laurent, Camille, et al.
Publicado: (2022) -
Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience
por: Mozas, Pablo, et al.
Publicado: (2020) -
Chemotherapy-Free Management of Follicular and Marginal Zone Lymphoma
por: Ollila, Thomas A, et al.
Publicado: (2021) -
Follicular lymphoma presenting like marginal zone lymphoma: A case report
por: Peng, Hao-Yu, et al.
Publicado: (2022) -
Estimating the Burden of Illness of Relapsed Follicular Lymphoma and Marginal Zone Lymphoma in Ontario, Canada
por: Kuruvilla, John, et al.
Publicado: (2023)